tisotumab vedotin-tftv
genmab,seagen
['tivdak', 'seagen']
genmab and seagen present data from tisotumab vedotin (tivdak ) clinical development program and additional cervical cancer research at asco 2022 annual meeting - release copenhagen, denmark, june 6, 2022 interim results of tisotumab vedotin plus p... 
CEO Of Digital Media Online